PTGS2 and Kaposi's sarcoma: Moreover, we were interested in the role of COX-2 in vGPCR angiogenicity and oncogenicity as this inflammatory mediator can be targeted by low-toxicity NSAIDs in KSHV infected cells [31,35,37,38], which makes it an interesting surrogate target for chemoprevention of KS.